Abstract
Purpose
The aim of the study was to develop a rapid and reproducible method to label LY2181308, an antisense oligonucleotide to Survivin, with carbon-11 in order to study its in vivo biodistribution and tumor uptake in rodents and its human dosimetry based on baboon data.
Methods
Randomly [11C] methylated LY2181308 was produced with [11C] methyl iodide. The biodistribution was performed in female Sprague–Dawley (SD) rats and EMT-6 tumor-bearing mice in the presence of nonradioactive LY2181308. Human dosimetry calculations were based on baboon PET studies.
Results
In SD rats, the kidney and liver were the organs with the most accumulation of radioactivity. Tumor uptake in mice was also relatively high after 5 min and remained constant for up to 1 h. Baboon dosimetry suggested that up to 42 mCi of radioactivity could be administered to human with a dose-limiting organ being the kidneys with a radiation dose of 32 µGy/MBq (0.118 rad/mCi).
Conclusions
[11C] Methylated LY2181308 to rodents and baboons showed its biodistribution, tumor uptake, and human dosimetry evaluation. These results should facilitate the understanding of the pharmacokinetics of LY2181308 prior to use as a potential new therapeutic agent in oncology as well as to warrant more in vivo validations as a potentially useful tumor-imaging agent.
Similar content being viewed by others
References
Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917–921
Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Rev Trends Mol Med 7:542–547
Zaffaroni N, Daidone MG (2002) Survivin expression and resistance to anticancer treatments: perspective for new therapeutic interventions. Drug Resist Updat (review) 5:65–72
Kallio MJ, Nieminen M, Eriksson JE (2001) Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit. FASEB J 15:2721–2723
Li F, Ambrosini G, Chu EY et al (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584
Olie RA, Simoes-Wust P, Baumann B et al (2000) A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60:2805–2809
Younes CK, Boisgard R and Tavitian B (2002) Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives. Curr Pharm Des 8:1451–1466
Dolle F, Hinnen F, Vaufrey F et al (1997) A general method for labeling oligodeoxynucleotides with F-18 for in vivo PET imaging. J Labl Comp Radiopharm 39:319–330
Tavitian B, Terrazzino S, Kuhnast B et al (1998) In vivo imaging of oligonucleotides with positron emission tomography. Nature Med 4:467–471
Dence CS, Sun X, Mach RH, Welch MJ (2005) [11C]-methylated LY2181308, an antisense oligonucleotide to survivin: radiochemical synthesis and preliminary rodent biodistribution studies. J Labl Comp Radiopharm 48:S161
Dence CS, Laforest R, Sharp TL, Mach RH, Welch MJ (2007) [11C]-methylated LY2181308, an antisense oligonucleotide to survivin: part II-human dosimetry calculation. J Labl Comp Radiopharm 50:S449
Saleem A, Ranson M, Callies S, Lahn M, Prenant C, Brown G, Mathews JC, Dence CS, McMahon A, Price P (2009) Microdosing imaging pharmacokinetic (PK) study of the anti-sense oligonucleotide (ASO) to Survivin (LY 2181308) using positron emission tomography (PET): a novel paradigm in clinical drug development. J Clin Oncol 27(No 15S):3578
USP 32-NF 27 (2009) First supplement chapter <467>
Iskandar ZA and Al-Joudi FS (2006) Expression of survivin in fetal and adult normal tissue of rat. Malaysian J Pathol 28:101–106
Sohn DM, Kim SY, Baek MJ et al (2006) Expression of survivin and clinical correlation in patients with breast cancer. Biomed Pharmacotherapy 60:289–292
Kennedy SM, O’Driscoll L, Purcell R et al (2003) Prognostic importance of survivin in breast cancer. Br J Cancer 88:1077–1083
Tanaka K, Iwamoto S, Gon G et al (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6:127–134
Acknowledgments
We thank Nicole Fettig, Margaret Morris, Paul Eisenbeis, and Mark Nolte for their contributions to the animal studies and Bill Margenau and Dave Ficke for isotope production. We also thank Lynne Jones, Karen Dotson, and Joseph B. Dence for their editorial assistance. This work was supported by Eli Lilly and Co, Indianapolis, IN, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dence, C.S., Laforest, R., Sun, X. et al. Radiochemical Synthesis, Rodent Biodistribution and Tumor Uptake, and Dosimetry Calculations of [11C] Methylated LY2181308. Mol Imaging Biol 12, 608–615 (2010). https://doi.org/10.1007/s11307-010-0319-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-010-0319-8